Ex-Anduril founders raise $30mn to build Europe’s synthetic battlefield for defence AI
Ex-Anduril founders raise $30mn to build Europe’s synthetic battlefield for defence AI

A London startup building the training grounds for Europe’s autonomous weapons has come out of stealth with $30mn. It is one of the region’s largest defence-tech seed rounds this year. Agon is not building the weapons themselves. It is building the inf…

Google’s new AI can now walk a humanoid across the room and tidy up, feet to fingertips
Google’s new AI can now walk a humanoid across the room and tidy up, feet to fingertips

Google DeepMind wants one AI brain to run every robot, and it just taught that brain to use its whole body. It has released Gemini Robotics 2, a family of models that can control a humanoid from its feet to its fingertips. The system can also coordinat…

To find out what customers think, this $2bn startup asks their AI twins
To find out what customers think, this $2bn startup asks their AI twins

A startup wants companies to stop asking real people what they think, and ask fake ones instead. Simile has raised $200m at a $2bn valuation to build “agentic twins,” AI stand-ins for real consumers that firms can survey by the million. Greenoaks led t…

Nscale owns the power and the data centres. For ~$1.65bn, it just bought the software too.
Nscale owns the power and the data centres. For ~$1.65bn, it just bought the software too.

Nscale, the London AI-cloud company that owns its own power and data centres, is buying its way up the stack. It has agreed to acquire Anyscale, the startup behind the widely used Ray software. Bloomberg reported the deal at about $1.65bn. Nscale annou…

AEREDIUM’s new patent wants to replace quarterly stablecoin audits with AI that never stops watching
AEREDIUM’s new patent wants to replace quarterly stablecoin audits with AI that never stops watching

The stablecoin industry has long relied on a familiar trust model: accounting firms periodically review reserve balances and publish attestations weeks after the underlying data was collected. For an asset class that moves around the clock, that approa…

Everyone’s building a ‘GPT for cells.’ Relation’s bet is manufacturing the data to train it.
Everyone’s building a ‘GPT for cells.’ Relation’s bet is manufacturing the data to train it.

The race to build an AI “foundation model of the cell” has a fuel problem. The biological data needed to train one is scarce, messy and inconsistent. Relation Therapeutics thinks the answer is to manufacture that data itself, and GSK is paying up to $1…

IBM just bought a quantum bet it doesn’t build. Days later, the payoff hit Nature.
IBM just bought a quantum bet it doesn’t build. Days later, the payoff hit Nature.

Six days ago, IBM agreed to buy a quantum-computing lab that builds a kind of qubit IBM does not. This week, the lab showed the world why. HRL Laboratories published a result in Nature on Wednesday: a silicon quantum processor that, in effect, runs its…

The AI race built faster chips. Now the chips are too fast for their own wires.
The AI race built faster chips. Now the chips are too fast for their own wires.

For three years, the AI race has been a race for faster chips. Eliyan just became a $1bn company by pointing out that the chips are now too fast for their own wires. The Santa Clara startup said it closed an oversubscribed $145m Series C at a $1bn valu…

G2A.COM’s Autonomous AI Agent Dave Helps Sellers Resolve 14,400 Support Tickets in 63 Days
G2A.COM’s Autonomous AI Agent Dave Helps Sellers Resolve 14,400 Support Tickets in 63 Days

Dave, a New AI-Powered Tool for Sellers, Helps Resolve 54% of Their Cases and Efficiently Manages Demand Spikes During AAA Game Launches. Now available in 180 countries, it has reduced the number of tickets submitted to Seller’s Support teams by 30%. G…

This Cambridge startup is building a ‘foundation model’ for the chest to speed drug trials
This Cambridge startup is building a ‘foundation model’ for the chest to speed drug trials

Most AI imaging startups build one model per disease. A Cambridge company has raised $20m to build a single model for the whole chest. Then it can spin the rest out of that. Qureight makes AI imaging tools for lung and heart clinical trials. It closed …